Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG

Bibliographic Details
Title: Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
Authors: Kirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, Lutz Gieselmann, Kanika Vanshylla, Maike Wirtz, Franziska Kleipass, Wibke Johannis, Philipp Schommers, Henning Gruell, Karl August Brensing, Roman-Ulrich Müller, Max Augustin, Clara Lehmann, Manuel Koch, Florian Klein, Veronica Di Cristanziano
Source: Microorganisms, Vol 9, Iss 4, p 733 (2021)
Publisher Information: MDPI AG, 2021.
Publication Year: 2021
Collection: LCC:Biology (General)
Subject Terms: pandemic, humoral response, neutralization, titer, protection, non-responder, Biology (General), QH301-705.5
More Details: Background: The investigation of the antibody response to SARS-CoV-2 represents a key aspect in facing the COVID-19 pandemic. In the present study, we compared the new Immundiagnostik IDK® anti-SARS-CoV-2 S1 IgG assay with four widely-used commercial serological assays for the detection of antibodies targeting S (spike) and NC (nucleocapsid) proteins. Methods: Serum samples were taken from an unbiased group of convalescent patients and from a negative control group. Sample were simultaneously analyzed by the new Immundiagnostik IDK® anti-SARS-CoV-2 S1 IgG assay, by the DiaSorin LIAISON® SARS-CoV-2 S1/S2 IgG assay, and by the Euroimmun anti-SARS-CoV-2 S1 IgG ELISA. Antibodies binding NC were detected by the Abbott SARS-CoV-2 IgG assay and by the pan-immunoglobulin immunoassay Roche Elecsys® anti-SARS-CoV-2. Moreover, we investigated samples of a group of COVID-19 convalescent subjects that were primarily tested S1 IgG non-reactive. Samples were also tested by live virus and pseudovirus neutralization tests. Results: Overall, the IDK® anti-SARS-CoV-2 S1 IgG assay showed the highest sensitivity among the evaluated spike (S) protein-based assays. Additionally, the Immundiagnostik assay correlated well with serum-neutralizing activity. Conclusions: The novel IDK® anti-SARS-CoV-2 S1 IgG assay showed high sensitivity and specificity, representing a valid option for use in the routine diagnostic.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2076-2607
Relation: https://www.mdpi.com/2076-2607/9/4/733; https://doaj.org/toc/2076-2607
DOI: 10.3390/microorganisms9040733
Access URL: https://doaj.org/article/6c630c7a08bd4ce88b38dcb9bbf93f92
Accession Number: edsdoj.6c630c7a08bd4ce88b38dcb9bbf93f92
Database: Directory of Open Access Journals
More Details
ISSN:20762607
DOI:10.3390/microorganisms9040733
Published in:Microorganisms
Language:English